Garuda - Garba Rujukan Digital

p-Index From 2020 - 2025

3.426

P-Index

This Author published in this journals

All Journal HAYATI Journal of Biosciences Smart Medical Journal Indonesian Journal of Cardiology Jurnal Respirologi Indonesia Jurnal Respirasi (JR) Health and Medical Journal World Nutrition Journal Sainstech Farma: Jurnal Ilmu Kefarmasian Cermin Dunia Kedokteran Indonesian Journal of Cancer eJournal Kedokteran Indonesia Kesmas: Jurnal Kesehatan Masyarakat Nasional (National Public Health Journal)

Zaini, Jamal

National Medical Team COVID-19, The Indonesian Society Of Respirology, Jakarta, Indonesia Department Of Pulmonology And Respiratory Medicine, Persahabatan General Hospital, Faculty Of Medicine Universitas Indonesia, Jakarta, Indonesia

Author-ID : 1936194

Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Earth & Planetary Sciences Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience Public Health

Published : 23 Documents Claim Missing Document

Claim Missing Document

Articles

1 2 3

The Proportion of Radiation Pneumonitis among Lung Cancer Patients in Persahabatan Hospital Dini Rizkie Wijayanti; Jamal Zaini; Achmad Hudoyo; Aziza Ghanie; Westi ATW
Indonesian Journal of Cancer Vol 14, No 2 (2020): June
Publisher : National Cancer Center - Dharmais Cancer Hospital

Background : Radiation-induced pulmonary toxicity occurs in patients with lung cancer who received irradiation. The objective of this study was to determine the proportion of radiation pneumonitis among lung cancer patients that were exposed to radiation treatment in Persahabatan Hospital. There is no data about proportion of radiation pneumonitis in Indonesia.Methods: This was a retrospective study conducted in Persahabatan Hospital during June 2013– July 2015 using the medical record of lung-cancer patients who received irradiation.Results: 33 lung-cancer patients fulfilled the inclusion criteria. Most of them were male (66.7%), in age ≥ 51 years (63.6%), had a smoking history (75.8%) with moderate Brinkman Index (60%), were given irradiation doses of 3,000–4,000 (60.6%) with irradiation fractions of 10–19 (60.6%), had no history of chemotherapy (54.5%), and were diagnosed with adenocarcinoma (66.7%) and stage-IV cancer (84.84%). The proportion of radiation pneumonitis based on chest X-ray (CXR) was 39.4%; which consisted of hazy ground-glass opacities, hazy ground-glass opacities, and fibrosis, and only fibrosis. There were significant differences in age, radiation doses, and history of chemotherapy with the proportion of radiation pneumonitis (p < .05).Conclusion: The proportion of radiation pneumonitis based on CXR was 39.4%. There were significant differences in age, radiation doses, and history of chemotherapy with the proportion of radiation pneumonitis.

Perilaku Merokok pada Mahasiswa Fakultas Kedokteran dan Fakultas Pertambangan Universitas Papua, Sorong Astrid B Rase; Jamal Zaini; Samuel S Kamalle; Siti Syahral Ain
eJournal Kedokteran Indonesia Vol 9, No. 1 - April 2021
Publisher : Faculty of Medicine Universitas Indonesia

Indonesia merupakan salah satu negara dengan prevalensi perokok tertinggi di dunia. Saat ini merokok masih menjadi gaya hidup di lingkungan mahasiswa, tetapi perilaku merokok pada populasi di wilayah TImur Indonesia terutama Papua masih jarang diteliti. Penelitian ini bertujuan untuk mengetahui perilaku merokok pada mahasiswa Fakultas Kedokteran (FK) dan fakultas non-kesehatan (Fakultas Teknik Pertambangan dan Perminyakan/FTPP). Studi ini menggunakan desain studi potong lintang. Pengambilan data dilakukan pada Maret 2019 dengan teknik total sampling dan instrument yang digunakan yaitu kuesioner tervalidasi dari Global Adult Tobacco Survey (GATS) dan Global Youth Tobacco Survey (GYTS). Didapatkan 113 responden mahasiswa FK dan 72 responden mahasiswa FTPP. Perilaku merokok 1 batang setiap hari dalam 30 hari terakhir didapatkan terbanyak pada mahasiswa FTPP (29,8%) dibandingkan FK (7,1%). Ditemukan juga kekerapan kebiasaan yang berpengaruh terhadap kesehatan seperti mengunyah sirih, mengunyah pinang, VAPE bahkan konsumsi alkohol pada populasi baik mahasiswa FK maupun mahasiswa FTPP. Prevalensi merokok, menyirih dan konsumsi alkohol pada mahasiswa fakultas teknik lebih tinggi daripada mahasiswa fakultas kedokteran dan perlu dilakukan penelitian terkait terjadinya gangguan kesehatan dimasa depan. Kata kunci: merokok, menyirih, mahasiswa kedokteran, mahasiswa teknik. Smoking Behavior among Medical and Engineering Students in Universitas Papua, Sorong Abstract Indonesia is among the highest prevalence of cigarette smoking in the world and it is a common lifestyle among undergraduate students. This study aims to measure smoking behaviour among undergraduate medical student and non medical students in West Papua. A cross sectional study with total sampling was done among undergraduate students in Faculty of Medicine and Faculty of Mining Engineering Universitas Papua, Sorong. Global Adults Tobacco Survey (GATS) and Global Youth Tobacco Survey (GYTS) questionnairre were administered with additional question regarding other habits that might be related to addiction such as betel nut chewing, consuming alcohol and vaping. There are 113 medical student and 72 non medical students were recruited. The prevalence of smoking among undergraduate medical students was 7.1% and 29.8% among undergraduate non medical students. Interestingly the prevalence of betel nut chewing is high among non medical students. The prevalence of smoking among undergraduate non medical students is higher compared with medical students in West Papua. The prevalence of betel-nut chewing and alcohol consumption were also high among non medical student and need further study regarding its health risk. Keywords: cigarette smoking, betel nut chewing, medical students, non medical students

Clinical Response and Safety of Alternating Daily Dosage of Crizotinib due to Side Effects in Advanced NSCLC patient harboring ROS1-rearrangement: A Case Report Jamal Zaini; Muhamad Rizqy Fadhillah; Sita Andarini
Jurnal Respirologi Indonesia Vol 43, No 2 (2023)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v43i2.201

Background: Advanced lung cancer has the lowest overall survival than other stage and tyrosine kinase inhibitor (TKI) are promising to prolong life and prevent disease progression. ROS1 rearrangement was very rare and constitute around 1.4 % of all NSCLC. Previous preclinical and clinical trial have reported the efficacy and safety of crizotinib against advanced NSCLC with ROS1 rearrangement, but little is known about its efficacy with nonstandard dosage.Case: A female, 58 years old, with no history of cancer nor smoking, came with persistent chest pain and cough for three months. The patient was then diagnosed with advanced lung cancer by FDG-PET CT Scan. The biopsy confirmed adenocarcinoma with genotyped ROS1-rearrangement. After receive standar dose of 200 mg bid, the patient intolerated and treatment plan was adjusted with 200 mg of alternated daily dosage (one-day on-off drug administration). Fortunately, the intolerance symptoms were alleviated and showed positive response during 3-years therapy.Discussion: Pulmonary tuberculosis has been linked to pneumothorax in HIV-associated TB patients. This study is done to better our understanding of the link between the two. The patient had active pulmonary tuberculosis as well as HIV and a rare case of bilateral pneumothorax in the ER.Conclusion: This case showed that advanced NSCLC with ROS1 rearrangement has positive response to crizotinib despite using alternating daily dose, with good response during 3 years and on.

Indonesian Society of Respirology (ISR) Consensus Statement on Lung Cancer Screening and Early Detection in Indonesia Sita Andarini; Elisna Syahruddin; Nathaniel Aditya; Jamal Zaini; Ferry Dwi Kurniawan; Sabrina Ermayanti; Noni Novisari Soeroso; Sri Melati Munir; Andreas Infianto; Ana Rima; Ungky Agus Setyawan; Laksmi Wulandari; Haryati Haryati; Ida Ayu Jasminarti; Arif Santoso
Jurnal Respirologi Indonesia Vol 43, No 2 (2023)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v43i2.455

Lung cancer is the leading cause of mortality for all cancer globally and in Indonesia. In Indonesia, lung cancer contributes to 12.6% of death of all cancer, making it the number one cause of cancer death, and 8.6% of all cancer incidence in 2018, behind breast, cervical, and colorectal cancer. The total cases per year are expected to almost double from 30,023 in 2018 to 54,983 cases in 2040. Smoking is among the risk factors for lung cancer, after occupational/environmental risk factors, history of lung fibrosis, and family history of cancer. There was a tendency of younger smokers in Indonesia and increased lung cancer incidence and prevalence in the younger population. The median age of lung cancer in Indonesia was younger than in any country, probably due to the younger age of smoking, early onset of carcinogens, asbestos use, and environmental. Lung cancer screening is a voluntary measure to detect lung cancer in the earliest stage, to find cancer at curable disease before symptoms appear in high-risk individuals. Lung cancer early detection is strategies to find cancer earlier after symptoms appear (cough, hemoptysis, dyspnea, chest pain). Low-dose computerized tomography of the thorax (LDCT) screening has been known to reduce lung cancer mortality compared to a chest x-ray (CXR). This Indonesian Society of Respirology consensus statement was aimed to give recommendations on lung cancer screening and early diagnosis in Indonesia.

Pulmonary Tuberculosis Coinfected with COVID-19 Compounded by Bacterial Superinfection: A Case Report and Critical Appraisal of The Evidence Regarding Its Mortality Kemal Akbar Suryoadji; Baiq Amalia Utami; Fairuzia Fiyanti Putri; Hilma Nur Faiza; Kezia Alicia Theresia Manik; Fathiyah Isbaniyah; Jamal Zaini
Jurnal Respirologi Indonesia Vol 43, No 2 (2023)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v43i2.226

Background: The WHO has declared COVID-19 as a global pandemic. However, Indonesia is also challenged by high burden of tuberculosis (TB). In this study, reported an active pulmonary TB case coinciding with COVID-19 but deceased due to bacterial infection. There is a need to further explore this new problem in developing countries to determine the prognosis of COVID-19 patients with tuberculosis infection.Methods: A comprehensive literature search was conducted by using databases such as The Cochrane Library, PubMed, Google Scholar, EBSCO-Host, and Scopus, including systematic reviews of cohort studies, cohorts, and case controls. As many as 309 studies were identified, after screening for duplicates and against the inclusion and exclusion criteria, three studies were included for critical appraisal.Results: The meta-analysis by Gao et al included two studies with an odds ratio (OR) of 1.4 [95% CI=0.1-18.93], the cohort study by Sy et al reported a relative risk (RR) of 2.17 [95% CI=1.4-3.37], and Motta et al showed that COVID-19 patients with tuberculosis had a mortality rate of 11.8% [95% CI=7.75-15.45]. Conclusion: TB has yet to be an identified as a major predictor of increased mortality in COVID-19 patients but can be considered a predictor of increased severity in COVID-19 patients. Studies with a bigger sample size and better study design are suggested to obtain new evidence.

Clinical Efficacy of Crizotinib as the First-Line Therapy of Advanced Non-Small-Cell Lung Carcinoma with ROS-1 Rearrangement: A Systematic Review Muhamad Rizqy Fadhillah; Jamal Zaini
Indonesian Journal of Cancer Vol 17, No 2 (2023): June
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v17i2.933

Background: Crizotinib is a drug designed to treat advanced NSCLC with ROS-1 rearrangement. Nevertheless, no reviews have assessed available studies to determine the efficacy and safety of first-line crizotinib against advanced NSCLC with ROS-1 rearrangement.Methods: PubMed, Cochrane Library, EBSCOHost, and ScienceDirect, were searched, filtered by inclusion and exclusion criteria, and read the full text. The researchers summarized and extracted efficacy as the primary outcome, including patients’ best response (complete response, partial response, stable disease, progressive disease, disease control rate, and objective response rate) and prognosis (overall survival rate and progression-free survival rate). Safety was also extracted as the secondary outcome.Results: Out of 91 articles electronically searched, four observational studies were included, extracted, and summarized descriptively. After full-text reading, entire studies were included. Across studies, the median PFS of the first line crizotinib varied from 14.9 months, 23.0 months, and 18.4 months with the median OS being 60 days to “Not Reach.” The patients’ best responses were similar among the studies. However, two out of four studies did not report the adverse event outcome. This study concluded that first-line crizotinib was safe.Conclusions: This systematic review suggests the potency of the first line of crizotinib therapy in advanced NSCLC patients. Regarding the current limitation of included studies, further higher quality with subsequent research in this scope is needed.

Primary Pulmonary Sarcoma Coinfected with Pulmonary Tuberculosis: A Case Report Dea Putri Audina; Sita Laksmi Andarini; Hana Khairina Putri Faisal; Prasenohadi Prasenohadi; Jamal Zaini; Herawati Hidajat
Indonesian Journal of Cancer Vol 17, No 3 (2023): September
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v17i3.991

Introduction: Pulmonary tuberculosis (TB) and malignancy are conditions with similar respiratory diseases and they are even known to coexist simultaneously. Therefore, accurate diagnosis of each disease is crucial to ensure precise treatment. This case study showed the coexistence of pulmonary TB and primary pulmonary sarcoma.Case Presentation: A 62-year-old male presented with a 3-month history of dyspnea, which worsened within 3 days. Before hospitalization, there were complaints of left chest pain, fatigue, loss of appetite, weight loss within 5 months, and night sweats. The patient who was a heavy smoker had experienced hemoptysis in the past 5 months. Upon physical examination, an increased respiratory rate and decreased oxygen saturation level. Furthermore, there were asymmetrical thorax movements, dull percussion on the left side, and decreased vesicular breathing sound on the left hemithorax, with no rhonchi or wheezing. A chest x-ray showed a destroyed left lung, while scanning confirmed left lung atelectasis and indicated a suspected mass within or around the left bronchus causing total obstruction in the main left bronchus. The bronchoscopy procedure identified a mass blocking the left main bronchus. However, a biopsy yielded inconclusive results. A rapid molecular test of TB detected Mycobacterium tuberculosis, which was discovered to be Rifampicin sensitive. As a result, the patient was treated daily with 4 fixed drug combinations for anti-TB. Despite the treatment, the complaint was not resolved within the next 3 months, as there was still a disease of cough in the form of mass-like phlegm, which uncovered a malignancy focus cell with differential diagnosis of pleomorphic sarcoma and sarcomatoid carcinoma.Conclusions: Lung malignancy not only overlapped with but also occurred simultaneously alongside lung TB. Therefore, it was crucial to establish a clear diagnosis in patients with chronic respiratory disease.

Diversity of Fungal Colonization in Respiratory Tract of NaÃ¯ve Lung Cancer and The Emergence of Voriconazole Resistant Aspergillus Jamal Zaini; Abul A'la Al Maududi; Zahrah Annisa; Denny Grecius Siregar; Findra Setianingrum; Mulyati Tugiran; Ridhawati Sjam; Robiatul Adawiyah; Anna Rozaliyani; Sita Andarini; Elisna Syahruddin
HAYATI Journal of Biosciences Vol. 30 No. 6 (2023): November 2023
Publisher : Bogor Agricultural University, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.4308/hjb.30.6.1139-1148

Fungal spores in the air can be inhaled and enter the human respiratory tract. The entry of fungi into the respiratory tract can cause colonization or infection depending on the host immune response. Fungal colonization is the first step into debilitating fungal disease in humans, especially in immunocompromised groups. The increased rate of drug-resistant fungi has been reported in human disease and the environment. This study aims to examine the diversity of fungal colonization in humans and the rate of fungal resistance to voriconazole. This cross-sectional study was done in patients with naÃ¯ve lung cancer who had not been previously treated with any cancer therapy nor given antifungal agent. Induced sputum from 70 subjects was collected and inoculated in the Sabouraud Dextrose Agar medium. Macroscopic and microscopic examinations were performed to identify fungal species. Voriconazole susceptibility tests were done using the disc diffusion method. This study found Candida albicans, Aspergillus niger, Aspergillus fumigatus, and Penicillium sp. among the most common lower respiratory tract colonies. This study also found the colonization of up to 5 species in a single subject. A high rate of voriconazole-resistant Aspergillus sp. was found (42.4%) among 59 isolates tested. Given that these subjects had never taken antifungal agents previously, the high rate of voriconazole resistance might be attributed to the environment, such as community and agriculture. Mitigation of antifungal use in the agricultural sector, fungal diversity in the environment, and clinical study of fungal colonization/ infection in other high-risk groups are needed.

Diagnostic Value of Saliva RT-PCR Test within Suspected SARS-CoV-2 Cases in Indonesia Andika Chandra Putra; Jamal Zaini; Asep Muhammad Ridwanuloh; Herjuno Ari Nugroho; Ryan Haryo Setyawan; Idris Idris; Ruby Setiawan; Pangda Sopha Sushadi; Ari Sulistyo Wulandari; Anky Zannati; Indriawati Indriawati; Eva Erdayani; Wahyuni Wahyuni; Dian Fitria Agustiyanti; Popi Hadi Wisnuwardhani; Zahrah Saniyyah; Wira Norman Azika; Budi Haryanto; Ahmad Rusdan Handoyo Utomo; Ratih Asmana Ningrum
Health and Medical Journal Vol 6, No 2 (2024): HEME May 2024
Publisher : Universitas Baiturrahmah

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33854/heme.v6i2.1494

Introduction: The ongoing SARS-CoV-2 pandemic has profoundly emphasized the pressing need for accurate and reliable diagnostic procedures. Given the potential health risks associated with nasopharyngeal swabs, there has been growing interest in seeking alternative diagnostic mediums. In this context, our study delved into evaluating saliva as a potential diagnostic tool, simultaneously assessing its efficiency in relation to patient demographics and their exhibited clinical symptoms. Methods: Spanning from May to December 2020, we conducted a comprehensive cross-sectional analysis. We meticulously examined medical records to gather insights on patient characteristics, existing health conditions, onset of symptoms, clinical manifestations, and compared the results obtained from both salivary and nasopharyngeal RT-PCR tests for SARS-CoV-2. Results: Among the individuals suspected of SARS-CoV-2 infection, the mean age stood at 52.4 years, with males representing 60.3% of this group. Interestingly, a significant 76.9% reported underlying health conditions, predominantly hypertension and diabetes. The most commonly reported symptoms encompassed respiratory challenges, notably coughing and shortness of breath, succeeded by symptoms like nausea, fever, and a general sense of fatigue. The performance of saliva tests, in terms of accuracy, appeared to be significantly influenced by the timing of symptom emergence. Conclusion: The RT-PCR tests utilizing saliva samples demonstrated considerable promise, especially during the early stages of symptom manifestation, providing a reliable alternative to traditional nasopharyngeal swabs. The findings suggest a superior diagnostic sensitivity when utilizing saliva during the initial phases of a SARS-CoV-2 infection.

The Cancer Mycobiome: A Highlight to Lung Cancer Yuwono, Edho; Zaini, Jamal; Rozaliyani, Anna
Jurnal Respirasi Vol. 10 No. 3 (2024): September 2024
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jr.v10-I.3.2024.265-271

Microbiota is a collection of microorganisms such as bacteria, fungi, viruses, and archaea, with bacteria being the most numerous in the human body. Meanwhile, the mycobiome consists of commensal fungi, which are a small part of the microbiota. Examples found in the human body, from the skin to the internal organs, play a role in the immune response, homeostasis, metabolism, and disease. The composition of mycobiome varies over time, and the human intestine is the most studied organ due to the diversity of microbiota. Furthermore, lung cancer is the leading cause of death in oncology patients worldwide. Various studies suggest that mycobiomes play a role in cancer associated with dysbiosis. Chronic inflammation, biofilm formation, and carcinogen products are parts of cancer pathogenesis. Metagenome analysis has provided information about the diversity of microbiota, specifically mycobiome in the human body. The common method for gene sequencing in the metagenome is next-generation sequencing (NGS). Analysis through metagenomes in chronic diseases such as cancer shows that mycobiomes play a role in the process of cancer formation. However, the causal relationship between mycobiomes and cancer remains unknown.

Co-Authors Abul A'la Al Maududi Achmad Hudoyo Agus Dwi Susanto Agustin, Heidy Ahmad Hudoyo Ahmad Rusdan Handoyo Utomo Ainun Wulandari Ana Rima Ana Rima Setijadi Andarini, Sita Andreas Infianto Anky Zannati Anna Rozaliyani Anwar Jusuf Arfiansyah, Mochammad Aris Ari Sulistyo Wulandari Arief Riadi Arifin Arif Santoso Arif Santoso Arifin Nawas Arifin Nawas Arifin, Arief Riadi Ary Indriana Savitri Asep Muhammad Ridwanuloh Astrid B Rase Aziza Ghanie Aziziah, Aziziah Bahtiar Husain Baiq Amalia Utami Bambang Dwi Hasto Baskoro, Hario Budhi Antariksa Budi Haryanto Budi Prasetyo Budi Prasetyo Cipuk Muhaswitri Dea Putri Audina Denny Grecius Siregar Dian Fitria Agustiyanti Dini Rizkie Wijayanti Drupadi Dillon Elisna Syahruddin Erlina Burhan Ermayanti, Sabrina Ermayanti, Sabrina Erni Mudhiati Eva Erdayani Fairuzia Fiyanti Putri Faisal Yunus Faisal Yunus Faisal, Hana Khairina Putri Fariz, Nurwidya Fathiyah Isbaniyah Ferry Dwi Kurniawan Findra Setianingrum Ginindha Izzati Sabila Hana Khairina Putri Faisal Hana Khairina Putri Faisal Hario Baskoro Harris Abdullah Haryati Haryati Haryati Haryati Hasto, Bambang Dwi Hasyim, Ammar Abdurrahman Herawati Hidajat Herjuno Ari Nugroho Hidayat, Moulid Hilma Nur Faiza Husain, Bahtiar Ida Ayu Jasminarti Idris Idris INDRA YOVI Indriawati Indriawati Infianto, Andreas Isbaniah, Fathiyah Jasminarti, Ida Ayu Kemal Akbar Suryoadji Kemalasari Nas Darisan Kezia Alicia Theresia Manik Kurniawan, Ferry Dwi Laksmi Wulandari Lisnawati Lisnawati Mia Elhidsi Muammar Emir Ananta Muhamad Rizqy Fadhillah Muhamad Rizqy Fadhillah Muhamad Rizqy Fadhillah Mulyati Tugiran Nathaniel Aditya Noni Novisari Soeroso Pane, Irene Audrey Davalynn Pangda Sopha Sushadi Popi Hadi Wisnuwardhani Prasenohadi Prasenohadi Putra, Andika Chandra Ratih Asmana Ningrum Ridhawati Sjam Ririen Razika Ramdhani Robiatul Adawiyah Romi Baginta Ruby Setiawan Rudi Kurniawan Ryan Haryo Setyawan Samoedro, Erlang Samuel S Kamalle Santoso, Andintia Aisyah Sarah Fitriani Satria Pratama Satria Pratama Savitri, Ary Indriana Seira Putri Boru Rambe Septiyani Monalisa Setyawan, Ungky Agus Shanty R. Kusumawardani Sita Andarini Sita Andarini Sita Andarini Sita Laksmi Andarini Siti Syahral Ain Sri Melati Munir Sri Melati Munir Tugas Ratmono Tugas Ratmono, Tugas Wahyuni Wahyuni Westi ATW Wira Norman Azika Yayi DB Susanto Yoga Yuniadi Yuwono, Edho Zahrah Annisa Zahrah Saniyyah

Title

Found 23 Documents
Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title Search

Found 23 Documents Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title

Found 23 Documents
Search